يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Esclerosi múltiple - Prognosi"', وقت الاستعلام: 1.65s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Bittner S, Zipp F] Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany. [Oh J] Division of Neurology, Department of Medicine, St Michael’s Hospital, University of Toronto, Toronto, Ontario M5S 3H2, Canada. [Kubala Havrdová E] Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague 116 36, Czech Republic. [Tintoré M] Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Brain
    Scientia

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Treatment response, Multiple Sclerosis, Neurofilament, Filaments citoplasmàtics, Disease, neurofilament, Updates, Neurofilament Proteins, Internal medicine, medicine, Humans, aminoácidos, péptidos y proteínas::proteínas::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos [COMPUESTOS QUÍMICOS Y DROGAS], Longitudinal Studies, Subclinical disease, Diagnosis::Prognosis [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Esclerosi múltiple - Imatgeria per ressonància magnètica, diagnóstico::pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Other subheadings::Other subheadings::/diagnostic imaging [Other subheadings], AcademicSubjects/SCI01870, business.industry, therapy response, Multiple sclerosis, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], biomarkers, Otros calificadores::Otros calificadores::/diagnóstico por imagen [Otros calificadores], Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, Peptides, and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins [CHEMICALS AND DRUGS], Prognosis, medicine.disease, Esclerosi múltiple - Prognosi, Magnetic Resonance Imaging, Clinical trial, Early results, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Biomarker (medicine), AcademicSubjects/MED00310, Neurology (clinical), business

    وصف الملف: application/pdf

  2. 2

    المساهمون: Institut Català de la Salut, [Comabella M, Sastre-Garriga J, Pinteac R, Fissolo N, Vidal-Jordana A, Montalban X] Unitat de Neuroimmunologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borras E] Proteomics Unit, Universitat Pompeu Fabra, Barcelona. [Villar LM] Departments of Neurology and Immunology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid. [Saiz A] Service of Neurology, Hospital Clinic and Institut d’Investigacions Biomèdiques August Pi Sunyer, University of Barcelona. [Martínez-Yélamos S] Department of Neurology, Bellvitge University Hospital, Barcelona, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona
    Scientia
    Neurology® Neuroimmunology & Neuroinflammation
    article-version (Version of Record) 3

    مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Enzymes and Coenzymes::Enzymes::Hydrolases::Glycoside Hydrolases::Chitinases [CHEMICALS AND DRUGS], enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple crónica progresiva [ENFERMEDADES], Esclerosi múltiple, Article, Multiple sclerosis, Glicosidases, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Chronic Progressive [DISEASES], Internal medicine, Cathepsin L1, medicine, Humans, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression [DISEASES], enzimas y coenzimas::enzimas::hidrolasas::glicósido hidrolasas::quitinasas [COMPUESTOS QUÍMICOS Y DROGAS], Shotgun proteomics, CSF albumin, biology, business.industry, Chitinases, Biochemical markers, Patient Acuity, Area under the curve, Middle Aged, Multiple Sclerosis, Chronic Progressive, Prognosis, Esclerosi múltiple - Prognosi, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad [ENFERMEDADES], Clinical trial, Neurology, Estudi de casos, Chitinase, Cohort, Marcadors bioquímics, Disease Progression, biology.protein, Biomarker (medicine), Female, Neurology (clinical), Case studies, business, Biomarkers, Follow-Up Studies

    وصف الملف: application/pdf